3rmx:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, F1240A, TOXIN
3rmx:B (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, F1240A, TOXIN
3rmx:C (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, F1240A, TOXIN
3rmx:D (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, F1240A, TOXIN
1a8d:A (GLY127) to (LYS210) TETANUS TOXIN C FRAGMENT | NEUROTOXIN, CLOSTRIDIAL, GANGLIOSIDE BINDING REGION
3rsj:A (GLY967) to (ASP1069) STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A | CLOSTRIDIUM BOTULINUM TYPE F, GANGLIOSIDE BINDING SITE, GD1A, TOXIN
3rsj:C (GLY967) to (LYS1050) STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A | CLOSTRIDIUM BOTULINUM TYPE F, GANGLIOSIDE BINDING SITE, GD1A, TOXIN
1af9:A (GLY990) to (LYS1073) TETANUS NEUROTOXIN C FRAGMENT | CLOSTRIDIAL NEUROTOXIN, TETANUS, RECEPTOR BINDING
2ouh:A (VAL98) to (ALA182) CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN COMPLEX WITH FRACTIONATED HEPARIN DP10 | TSP-1, TSPN-1, HBD, FRACTIONATED HEPARIN, DP10, CELL ADHESION
3es6:B (LYS16) to (VAL117) CRYSTAL STRUCTURE OF THE NOVEL COMPLEX FORMED BETWEEN ZINC 2- GLYCOPROTEIN (ZAG) AND PROLACTIN INDUCIBLE PROTEIN (PIP) FROM HUMAN SEMINAL PLASMA | MAJOR HISTOCOMPATIBILITY COMPLEX, PROTEIN-PROTEIN COMPLEX, PROLACTIN INDUCIBLE PROTEIN, ZINC 2-GLYCOPROTEIN, ZAG-PIP COMPLEX, GLYCOPROTEIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, ACTIN-BINDING, CELL ADHESION
1d0h:A (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE | BETA TREFOIL, JELLY-ROLL, TOXIN
1dfq:A (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID | BETA TREFOIL, JELLY-ROLL, TOXIN, CARBOHYDRATE
1diw:A (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE | BETA TREFOIL, JELLY-ROLL, TOXIN
1dll:A (GLY990) to (LYS1088) THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE | BETA TREFOIL, JELLY ROLL, TOXIN
4isq:A (GLY963) to (GLN1045) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
4isq:B (GLY963) to (GLN1045) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
4isq:C (GLY963) to (GLN1045) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
4isr:A (GLY963) to (GLN1045) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
4isr:B (GLY963) to (GLN1045) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
4isr:C (GLY963) to (PHE1044) BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II | MEMBRANE BINDING, SYNAPTOTAGMIN AND GANGLIOSIDE BINDING, TOXIN
1epw:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B | BOTULINUM, ZINC, METALLOPROTEASE, TRANSMEMBRANE, NEUROTOXIN, HYDROLASE
4jra:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C | BETA-HELIX, VESICLES, LUMEN, TOXIN, HYDROLASE
2erf:A (VAL98) to (ILE181) CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN AT 1.45A RESOLUTION | THROMBOSPONDIN-1, TSP-1, N-TERMINAL TSPN, HBD, SUGAR BINDING PROTEIN
1fv2:A (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B | TOXIN, CARBOHYDRATE, GANGLIOSIDE, MULTI-VALENT BINDING, RECEPTOR
1fv3:A (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B | TOXIN, CARBOHYDRATE, GANGLIOSIDE, MULTI-VALENT BINDING, RECEPTOR
1fv3:B (GLY990) to (LYS1073) THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B | TOXIN, CARBOHYDRATE, GANGLIOSIDE, MULTI-VALENT BINDING, RECEPTOR
4kbb:A (GLY961) to (PHE1042) STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A | TOXIN BINDING DOMAIN, SYNAPTOTAGMIN AND GANGLIOSIDE, SIGNALING PROTEIN-TOXIN COMPLEX
4kbb:B (LYS963) to (LYS1043) STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A | TOXIN BINDING DOMAIN, SYNAPTOTAGMIN AND GANGLIOSIDE, SIGNALING PROTEIN-TOXIN COMPLEX
4yz3:A (SER144) to (GLY233) CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH OSELTAMIVIR. | SIALIDASE, NEURAMINIDASE, BETA-PROPELLER, CBM40, HYDROLASE
4yz3:B (SER144) to (GLY233) CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH OSELTAMIVIR. | SIALIDASE, NEURAMINIDASE, BETA-PROPELLER, CBM40, HYDROLASE
4yz4:A (VAL148) to (LEU232) CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANC, IN COMPLEX WITH N- ACETYLNEURAMINIC ACID. | SIALIDASE, NEURAMINIDASE, BETA-PROPELLER, CBM40, HYDROLASE
3hmy:A (GLY990) to (LYS1073) CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 | TETANUS NEUROTOXIN, GT2, GANGLIOSIDE, CARBOHYDRATE BINDING POCKET, DISULFIDE BOND, HYDROLASE, METAL-BINDING, METALLOPROTEASE, NEUROTOXIN, PROTEASE, TOXIN
3hn1:A (GLY990) to (LYS1073) CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 AND LACTOSE | GANGLIOSIDE GT2, LACTOSE, RECEPTOR BINDING POCKET, DISULFIDE BOND, HYDROLASE, METAL-BINDING, METALLOPROTEASE, NEUROTOXIN, PROTEASE, TOXIN
1s0c:A (LYS962) to (PHE1041) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0 | BOTULINUM, NEUROTOXIN, PH, METALS, TOXIN, HYDROLASE
1s0g:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM | BOTULINUM, NEUROTOXIN, PH, METALS, TOXIN, HYDROLASE
3v0a:B (GLY929) to (SER1007) 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA | BOTULINUM NEUROTOXIN, TOXIN, NEUROTOXIN ASSOCIATED PROTEIN, PROGENITOR TOXIN COMPLEX, VHH BOUND INTERLOCKED COMPLEX, NTNHA
2vu9:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B | HYDROLASE, METALLOPROTEASE, NEUROTOXIN, GANGLIOSIDE, METAL-BINDING, TOXIN, PROTEASE, MEMBRANE, RECEPTOR, SECRETED
2vua:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN | GANGLIOSIDE, RECEPTOR, TOXIN, MEMBRANE, SECRETED, METAL-BINDING, HYDROLASE, METALLOPROTEASE, NEUROTOXIN, PROTEASE
2vxr:A (GLY968) to (LYS1051) CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN | TOXIN, HYDROLASE, NEUROTOXIN, GANGLIOSIDE, PROTEASE, RECEPTOR, SECRETED, BOTULINUM, BINDING DOMAIN, METALLOPROTEASE
4zkt:B (GLY894) to (ASN974) CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN | BONT/E-NTNHE HETERO-DIMER, ACIDIC CLUSTER, DOMAIN SWAP, PROGENITOR COMPLEX, HYDROLASE-TOXIN COMPLEX
4zkt:D (GLY894) to (ASN974) CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN | BONT/E-NTNHE HETERO-DIMER, ACIDIC CLUSTER, DOMAIN SWAP, PROGENITOR COMPLEX, HYDROLASE-TOXIN COMPLEX
4zkt:F (GLY894) to (ASN974) CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN | BONT/E-NTNHE HETERO-DIMER, ACIDIC CLUSTER, DOMAIN SWAP, PROGENITOR COMPLEX, HYDROLASE-TOXIN COMPLEX
3vuo:A (GLY928) to (ASN1008) CRYSTAL STRUCTURE OF NONTOXIC NONHEMAGGLUTININ SUBCOMPONENT (NTNHA) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947 | PROTECTION OF BOTULINUM NEUROTOXIN, BOTULINUM NEUROTOXIN, TOXIN
1i1e:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN | BOTULINUM, NEUROTOXIN, METALLOPROTEASE, COMPLEX, DOXORUBICIN, HYDROLASE
4mae:B (ASN429) to (LYS502) METHANOL DEHYDROGENASE FROM METHYLACIDIPHILUM FUMARIOLICUM SOLV | DEHYDROGENASE, PQQ, LANTHANIDE ION, CERIUM ION, OXIDOREDUCTASE
2yd8:A (ASP41) to (GLU126) CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR IN COMPLEX WITH SUCROSE OCTASULPHATE | HYDROLASE, RPTPF
2nyy:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
2nz9:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
2nz9:B (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2 | BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX
4pbo:A (GLU61) to (LEU136) CRYSTAL STRUCTURE OF ZEBRAFISH SHORT-CHAIN PENTRAXIN PROTEIN WITHOUT CALCIUM IONS | ACUTE PHASE PROTEIN, PENTRAXIN, IMMUNE SYSTEM
4pbp:A (GLU61) to (LEU136) CRYSTAL STRUCTURE OF ZEBRAFISH SHORT-CHAIN PENTRAXIN PROTEIN | ACUTE PHASE PROTEIN, PENTRAXIN
4pbp:B (GLU61) to (LEU136) CRYSTAL STRUCTURE OF ZEBRAFISH SHORT-CHAIN PENTRAXIN PROTEIN | ACUTE PHASE PROTEIN, PENTRAXIN
4pbp:C (GLU61) to (LEU136) CRYSTAL STRUCTURE OF ZEBRAFISH SHORT-CHAIN PENTRAXIN PROTEIN | ACUTE PHASE PROTEIN, PENTRAXIN
1yyn:A (GLY990) to (LYS1073) A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN | TETANUS TOXIN, GD3, GANGLIOSIDE, X-RAY CRYSTALLOGRAPHY, BETA-TREFOIL, INHIBITORS, HYDROLASE
1za4:A (VAL98) to (ILE181) CRYSTAL STRUCTURE OF THE THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN COMPLEX WITH ARIXTRA | TSP-1, NTSP-1, HBD, ARIXTRA, CELL ADHESION
4avs:A (VAL63) to (LEU133) STRUCTURE OF N-ACETYL-L-PROLINE BOUND TO SERUM AMYLOID P COMPONENT | SUGAR BINDING PROTEIN, GLYCOPROTEIN, DISULFIDE BOND, LECTIN, METAL-BINDING
3azv:A (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN | BETA-TREFOIL FOLD, BETA-SHEET JELLYROLL, RECEPTOR BINDING, GANGLIOSIDE, EXTRA-CELLULAR, TOXIN
3azv:B (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN | BETA-TREFOIL FOLD, BETA-SHEET JELLYROLL, RECEPTOR BINDING, GANGLIOSIDE, EXTRA-CELLULAR, TOXIN
3azw:A (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN | BETA-TREFOIL FOLD, BETA-SHEET JELLYROLL FOLD, TOXIN
3azw:B (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN | BETA-TREFOIL FOLD, BETA-SHEET JELLYROLL FOLD, TOXIN
3bop:C (TYR140) to (GLY218) STRUCTURE OF MOUSE BETA-NEUREXIN 2D4 | BETA-NEUREXIN 2D4, LNS6, LECTIN, CELL ADHESION
3bta:A (LYS974) to (LYS1055) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A | NEUROTOXIN, ZINC PROTEASE, SUGAR BINDING PROTEIN, TRANSLOCATION
3n7j:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN | BOTULINUM NEUROTOXIN, HCR/D, GANGLIOSIDE BINDING LOOP, TOXIN
3n7k:A (GLY967) to (GLU1049) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN | BOTULINUM NEUROTOXIN, GANGLIOSIDE GD1B, HCR/C, GANGLIOSIDE BINDING LOOP, TOXIN
3n7k:B (GLY967) to (GLU1049) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN | BOTULINUM NEUROTOXIN, GANGLIOSIDE GD1B, HCR/C, GANGLIOSIDE BINDING LOOP, TOXIN
3n7l:A (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN | BOTULINUM NEUROTOXIN, HCR/D-SA, GANGLIOSIDE BINDING LOOP, TOXIN
3n7m:A (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995 | BOTULINUM NEUROTOXIN, W1252A MUTANT, GM1A, GANGLIOSIDE BINDING LOOP, TOXIN
3obr:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN | LIGAND BINDING, GANGLIOSIDES, SNARES, HYDROLASE
3obt:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID | NEUROTOXIN, GANGALIOSIDE, HYDROLASE
3ogg:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D | BOTULINUM NEUROTOXIN, SEROTYPE D, RECEPTOR BINDING DOMAIN, JELLY ROLL TREFOIL FOLD, RECEPTOR BINDING, GANGLIOSIDES, MEMBRANE TO CYTOPLASM, TOXIN
3pme:A (GLY965) to (GLY1048) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE | STRUCTURAL GENOMICS, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, BOTULINUM NEUROTOXIN, RECEPTOR BINDING DOMAIN, GANGLIOSIDE, PHOSPHATIDYLETHANOLAMINE, MOSAIC SEROTYPE, TOXIN
3pvn:B (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:G (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:H (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:I (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:J (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:M (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:N (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:Q (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvn:T (GLU62) to (LEU135) TRICLINIC FORM OF HUMAN C-REACTIVE PROTEIN IN COMPLEX WITH ZINC | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvo:H (GLU62) to (GLY128) MONOCLINIC FORM OF HUMAN C-REACTIVE PROTEIN | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvo:P (GLU62) to (GLY136) MONOCLINIC FORM OF HUMAN C-REACTIVE PROTEIN | PENTRAXIN FAMILY, IMMUNE SYSTEM
3pvo:T (GLU62) to (GLY136) MONOCLINIC FORM OF HUMAN C-REACTIVE PROTEIN | PENTRAXIN FAMILY, IMMUNE SYSTEM
4f83:A (GLY965) to (GLY1048) CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE | STRUCTURAL GENOMICS, NIAID, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID, BOTULINUM NEUROTOXIN, MOSAIC SEROTYPE C/D, TOXIN
3r05:B (PHE959) to (GLY1036) STRUCTURE OF NEUREXIN 1 ALPHA (DOMAINS LNS1-LNS6), WITH SPLICE INSERT SS3 | SYNAPTIC ADHESION MOLECULE, CELL ADHESION
3r4s:A (GLY967) to (PHE1048) CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES | BOTULINUM TOXINS, GANGLIOSIDES, HYDROLASE
3r4s:B (GLY967) to (PHE1048) CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES | BOTULINUM TOXINS, GANGLIOSIDES, HYDROLASE
3r4u:A (GLY967) to (PHE1048) CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES | BOTULINUM TOXINS, GANGLIOSIDES, HYDROLASE
3r4u:B (GLY967) to (PHE1048) CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES | BOTULINUM TOXINS, GANGLIOSIDES, HYDROLASE
5jlv:B (GLY973) to (LYS1056) RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C | GLYCOSYLATION, BOTULINUM NEUROTOXIN, RECEPTOR BINDING DOMAIN, HYDROLASE
5jmc:A (GLY973) to (LYS1056) RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C | HYDROLASE
5jmc:E (GLY973) to (LYS1056) RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C | HYDROLASE
5jmc:G (GLY973) to (LYS1056) RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C | HYDROLASE
4fvv:A (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C | BOTULINUM TOXIN, GANGLIOSIDE BING LOOP, GANGLIOSIDE, TOXIN
4fvv:B (GLY963) to (GLN1045) CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C | BOTULINUM TOXIN, GANGLIOSIDE BING LOOP, GANGLIOSIDE, TOXIN
3rmy:A (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, W1238A, TOXIN
3rmy:B (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, W1238A, TOXIN
3rmy:C (LYS963) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, W1238A, TOXIN
3rmy:D (GLY961) to (GLY1044) CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING LOOP, W1238A, TOXIN
3ffz:A (GLY949) to (LYS1032) DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION | BOTULINUM NEUROTOXIN SEROTYPE E, BOTULISM, DOMAIN ORGANIZATION, ENDOPEPTIDASE, TRANSLOCATION, HYDROLASE, MEMBRANE, METAL-BINDING, METALLOPROTEASE, NEUROTOXIN, PROTEASE, SECRETED, TOXIN, TRANSMEMBRANE, ZINC
3fuo:A (GLY972) to (LYS1055) THE CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A | BOTULINUM NEUROTOXIN, GANGLIOSIDE BINDING, HYDROLASE, MEMBRANE, METAL-BINDING, METALLOPROTEASE, NEUROTOXIN, PHARMACEUTICAL, PROTEASE, SECRETED, TOXIN, TRANSMEMBRANE, ZINC
4iqp:A (GLY973) to (LYS1056) CRYSTAL STRUCTURE OF HCRA-W1266A | BOTULINUM NEUROTOXIN, RECEPTOR BINDING DOMAIN, GANGLIOSIDE BINDING LOOP, TOXIN
1f31:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE | BOTULINUM, ZINC, METALLOPROTEASE, TRANSMEMBRANE, NEUROTOXIN, COMPLEX, GANGLIOSIDE
2es3:B (VAL98) to (ILE181) CRYSTAL STRUCTURE OF THROMBOSPONDIN-1 N-TERMINAL DOMAIN IN P1 FORM AT 1.85A RESOLUTION | THROMBOSPONDIN-1, TSP-1, TSPN, HBD, SUGAR BINDING PROTEIN
1g9a:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3) | BOTULINUM, NEUROTOXIN, INHIBITOR, COMPLEX, HYDROLASE
1s0d:A (GLY960) to (LYS1042) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5 | BOTULINUM, NEUROTOXIN, PH, METALS, TOXIN, HYDROLASE
1s0e:A (GLY960) to (PHE1041) CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0 | BOTULINUM, NEUROTOXIN, PH, METALS, TOXIN, HYDROLASE
3v0b:B (GLY929) to (SER1007) 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA | VHH FREE INLOCKED COMPLEX, BOTULINUM NEUROTOXIN, TOXIN
1yxw:A (GLY990) to (LYS1073) A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN | TETANUS TOXIN, GD3, GANGLIOSIDE, X-RAY CRYSTALLOGRAPHY, BETA-TREFOIL, INHIBITORS, HYDROLASE
1z0h:A (LYS962) to (PHE1041) N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B | CLOSTRIDIUM BOTULINUM, BINDING DOMAIN, X-RAY CRYSTALLOGRAPHY, GANGLIOSIDES, HYDROLASE
3poy:A (PHE975) to (GLY1052) CRYSTAL STRUCTURE OF THE ALPHA-NEUREXIN-1 ECTODOMAIN, LNS 2-6 | LNS, LAMININ NEUREXIN SEX HORMONE-BINDING GLOBULIN, EGF, EPIDERMAL GROWTH FACTOR, SYNAPTIC ADHESION PROTEIN, NEUROLIGIN, NLGN, PRESYNAPTIC, NEUREXIN, NRXN, CELL ADHESION